eli lilly glp 1 drug launches GLP-1 pill, kicking off showdown with Novo Nordisk Eli Lilly Just Launched a
Description
No commitment: Month-to-month billing
Although dedicated trials of GLP-1RAs in AITD are lacking, preliminary reports suggest potential impacton thyroid volume, thyroid function, and autoimmune activity
A more mindful, wellness-forward approach to GLP-1 use
GLP-1 receptor agonists stimulate the release of insulin, reduce glucagon secretion, and slow down gastric emptying
What impact will they have over the next 5 years?
